When was Integrated Diagnostics founded?

Integrated Diagnostics was founded in 2005 and raised its 1st funding round within a year of its incorporation.

Where is Integrated Diagnostics located?

Integrated Diagnostics is headquartered in Boulder, United States.

Who is the current CEO of Integrated Diagnostics?

Albert Luderer of Integrated Diagnostics.

How many employees does Integrated Diagnostics have?

As of Dec 31, 2017, Integrated Diagnostics has 17 employees, reflecting a 22% year-over-year growth in headcount.

Is Integrated Diagnostics a funded company?

Integrated Diagnostics is a funded company, having raised a total of $82.8M across 6 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on 2005.

When was the latest funding round of Integrated Diagnostics?

Integrated Diagnostics' latest funding was a $***** Series C round on Dec 08, 2016, with participation from 2 investors. Its primary sector is Oncology. In United States, the Oncology sector has seen $1.23B in funding in 2026 to date.

Where does Integrated Diagnostics rank among its competitors?

Integrated Diagnostics ranks 15th amongst 38 active competitors, of which 13 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Riverain Tech, which secured $8.25M in Dec, 2025.

Who are the top competitors of Integrated Diagnostics?

Integrated Diagnostics' top competitors include Biodesix, ONCOHOST and OncoCyte. Among them, Riverain Tech secured the most recent funding round in December, 2025.

Integrated Diagnostics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Integrated Diagnostics (Indi) is developing blood based diagnostics for oncology by following a systems biology based approach. Its flagship product, the Xpresys Lung test claims to detect the molecular changes in proteins associated with the presence of lung cancer and provide a non-invasive assessment of pulmonary nodules. Patient blood is analyzed by mass spectrometry that provides specific detection of target proteins. When combined with clinical assessment, Xpresys Lung claims to be able to help reduce unnecessary invasive procedures

Website: indidx.com
Email ID: *****@indidx.com

Key Metrics

Founded Year

2005

Location

Boulder, United States

Stage

Acqui-Hired

Total Funding

$82.8M in 6 rounds

Latest Funding Round

Series C, Dec 08, 2016, $*****

Investors

InterWest Partners & 6 more

Ranked

15^th among 38 active competitors

Employee Count

17 as on Dec 31, 2017

Similar Companies

Biodesix & 47 more

View Integrated Diagnostics' full profile

Integrated Diagnostics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Integrated Diagnostics Inc CIN: 264422484 , Germany, Active		-	17 (As on Dec 31, 2017)

Integrated Diagnostics has raised a total funding of $82.8M over 6 rounds. Its first funding round was on 2005. Its latest funding round was a Series C round on Dec 08, 2016 for $*****. 2 investors participated in its latest round. Integrated Diagnostics has 7 institutional investors.

Here is the list of recent funding rounds of Integrated Diagnostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 08, 2016	5197926	Series C	5734101	9220634	6615609	4401709
May 06, 2014	9888086	Series B	1226390	3415317	3145679	4048965
Apr 29, 2014	4482333	Conventional Debt	7553194	3677532	9361713	Life Sciences Alternative Funding

Access funding benchmarks and valuations. Sign up today!

View details of Integrated Diagnostics's funding rounds and investors

Integrated Diagnostics' employee count trend

Integrated Diagnostics has 17 employees as of Dec 17. The total employee count is 21.0% more than what it was in Dec 16. Here is Integrated Diagnostics's employee count trend over the years:

Employee count trend for Integrated Diagnostics

Uncover Integrated Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Integrated Diagnostics include Biodesix, ONCOHOST and OncoCyte. Here is the list of Top 10 competitors of Integrated Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Biodesix 2005, Boulder (United States), Public	Developer of diagnostics assays for the detection of cancer	$200M	Lincoln Park Capital, Perceptive Advisors ... & 1 others	75/100
2nd	ONCOHOST 2017, Binyamina Giv at Ada (Israel), Series C	AI-based oncology therapy plan solution for professionals	$43M	OurCrowd, ALIVE & 5 others	61/100
3rd	OncoCyte 2009, Irvine (United States), Public	Developer of non-invasive diagnostic tests solutions for the treatment of cancer	$15.3M	Geode Capital, Connor, Clark & Lunn Financial Group ... & 5 others	60/100
4th	Oxford Cancer Analytics 2018, Oxford (United Kingdom), Series A	Provider of a platform for detection of lung cancer	$16.5M	Eka Ventures, Cross Border Impact Ventures ... & 12 others	59/100
5th	Riverain Tech 2008, Miamisburg (United States), Series A	AI-powered solutions transforming cardiothoracic diagnosis through advanced medical imaging software	$23.2M	Ping An, Myrian Capital	56/100
6th	Mursla 2017, London (United Kingdom), Seed	Provider of diagnostic device for cancer detection	$547K	Future Fund, TA Ventures & 26 others	55/100
7th	Amadix 2010, Madrid (Spain), Series A	Provider of diagnostic tools to support personalized cancer treatment	$6.87M	Alentia, Inveready & 8 others	54/100
8th	Oncimmune 2006, Nottingham (United Kingdom), Acquired	Developer of diagnostics and risk assessment solutions for lung cancer	-	WG Partners, Balderton Capital & 9 others	53/100
9th	Cizzle Biotechnology 2005, York (United Kingdom), Public	Developer of blood tests for early lung cancer detection	$1.98M	Braveheart Investment Group, Finance Yorkshire ... & 2 others	50/100
10th	Inivata 2014, Cambridge (United Kingdom), Acquired	Developer of liquid biopsy platform for detecting cancer	$189M	Cambridge Capital Group, Soleus Capital & 23 others	49/100
15th	Integrated Diagnostics 2005, Boulder (United States), Acqui-Hired	Blood-based diagnostics for oncology.	$82.8M	TriplePoint Capital, Dievini & 5 others	42/100